These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2914591)

  • 1. Fatal paralytic ileus following vindesine chemotherapy in a patient with myeloma-associated amyloidosis.
    Kanoh T
    Eur J Haematol; 1989 Jan; 42(1):108. PubMed ID: 2914591
    [No Abstract]   [Full Text] [Related]  

  • 2. Itraconazole-enhanced vindesine neurotoxicity in adult acute lymphoblastic leukaemia.
    Chen S; Wu D; Sun A; Qiu H; Jin Z; Tang X; Miao M; Fu Z; Ma X; Han Y; Hu X
    Am J Hematol; 2007 Oct; 82(10):942. PubMed ID: 17617780
    [No Abstract]   [Full Text] [Related]  

  • 3. Strategy to reduce bortezomib-induced paralytic ileus in patients with myeloma and impaired renal function.
    Keating M; Dasanu CA
    BMJ Case Rep; 2016 Nov; 2016():. PubMed ID: 27899388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [RS3PE syndrome associated to AL-amyloidosis and multiple myeloma, with intestinal pseudo-obstruction].
    Morán Blanco A; Blanco Suárez MD; Herrera Rubio JA; Borrego Galán JC
    Med Clin (Barc); 2003 Jan; 120(2):79. PubMed ID: 12570921
    [No Abstract]   [Full Text] [Related]  

  • 5. Combination chemotherapy with MCNU, vindesine, melphalan, and prednisolone (MCNU-VMP therapy) in induction therapy for multiple myeloma. Japan Myeloma Study Group.
    Imamura Y; Takagi T; Yawata Y; Nishinarita S; Kosaka M; Mikuni C; Takatsuki K; Sezaki T; Mori M; Tsuchiya J
    Int J Hematol; 1994 Feb; 59(2):113-23. PubMed ID: 8018904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Once-weekly bortezomib plus dexamethasone therapy induced complete response, reducing severe gastrointestinal adverse events for a patient with relapsed multiple myeloma - a case report].
    Fukushima T; Iwao H; Sakai T; Sato T; Nakamura T; Nakajima A; Miki M; Sawaki T; Fujita Y; Tanaka M; Masaki Y; Umehara H
    Gan To Kagaku Ryoho; 2012 May; 39(5):805-7. PubMed ID: 22584336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of rhG-CSF in patients with neutropenia induced by chemotherapy for multiple myeloma].
    Togawa A; Mizoguchi H; Toyama K; Urabe A; Ohasi Y; Takaku F
    Rinsho Ketsueki; 2000 Feb; 41(2):115-22. PubMed ID: 10723240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gentle yet effective treatment for elderly patients with refractory or relapsing multiple myeloma.
    Manoharan A
    Am J Hematol; 2000 Sep; 65(1):81-2. PubMed ID: 10936870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide for the treatment of leptomeningeal multiple myeloma.
    Yutaka H; Mariko Y; Shinichiro O; Kunihiko M; Yusuke T; Yasuo I
    Eur J Haematol; 2006 Apr; 76(4):358-9. PubMed ID: 16519710
    [No Abstract]   [Full Text] [Related]  

  • 10. Paralytic ileus associated with a combination of dacarbazine-nimustine hydrochloride-vincristine chemotherapy.
    Takata Y; Hayashi S; Ohno T; Dekio S
    J Dermatol; 1997 Oct; 24(10):682-3. PubMed ID: 9375471
    [No Abstract]   [Full Text] [Related]  

  • 11. [A case of intestinal pseudo-obstruction complicating systemic amyloidosis with multiple myeloma].
    Kawai M; Yamawake N; Fujita K; Matsuda S; Awatsu R; Oda H; Kamisaka K; Maezawa H; Togo S; Minakuchi H
    Nihon Naika Gakkai Zasshi; 1987 Aug; 76(8):1245-9. PubMed ID: 3681097
    [No Abstract]   [Full Text] [Related]  

  • 12. [Multiple myeloma preceding myelodysplastic syndrome with eosinophilia and der (1;7)].
    Matano S; Kobayashi K; Nakamura S; Yoshida T
    Rinsho Ketsueki; 1994 Nov; 35(11):1310-4. PubMed ID: 7823398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Improved prognosis of generalized AL-amyloidosis in a patient with multiple myeloma treated according to the VAD protocol].
    Sarkisova IA; Rameev VV; Kozlovskaia LV; Andreeva NE
    Ter Arkh; 2003; 75(8):81-2. PubMed ID: 14520860
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fatal hepatic failure due to AL amyloidosis in a patient with multiple myeloma].
    Tabata S; Kurata M; Takeda J; Funayama Y; Yamauchi N; Aoki K; Kato A; Ono Y; Arima H; Takiuchi Y; Nagano S; Matsushita A; Imai Y; Ishikawa T; Takahashi T
    Rinsho Ketsueki; 2012 Nov; 53(11):1906-10. PubMed ID: 23257671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Early onset of paralytic ileus caused by simultaneous administration of bortezomib and azole antifungals in multiple myeloma patients].
    Koda Y; Mori T; Shimizu T; Kato J; Yamane A; Sadahira K; Tsukada Y; Yokoyama K; Hashimoto N; Hattori Y; Okamoto S
    Rinsho Ketsueki; 2012 Aug; 53(8):760-4. PubMed ID: 22975816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vindesine in refractory multiple myeloma.
    van der Lelie H; Monasch E; Pegels HG; von dem Borne AE
    Cancer; 1986 Jan; 57(2):226-9. PubMed ID: 3942957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple myeloma complicated by congestive heart failure following first administration of recombinant alpha-interferon.
    Kobayashi T; Sato Y; Hasegawa Y; Nagasawa T; Yoda Y; Abe T
    Intern Med; 1992 Jul; 31(7):936-40. PubMed ID: 1450506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare presentation of intestinal amyloidosis with acute intestinal pseudo-obstruction and perforation.
    Ng SB; Busmanis IA
    J Clin Pathol; 2002 Nov; 55(11):876. PubMed ID: 12401832
    [No Abstract]   [Full Text] [Related]  

  • 19. Fatal acute interstitial pneumonia induced by low-dose doxorubicin and vindesine.
    Isawa T; Ono R; Motomiya M; Tamahashi N
    Tohoku J Exp Med; 1989 Jun; 158(2):149-54. PubMed ID: 2549658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paralytic ileus following "subcutaneous bortezomib" therapy: focus on the clinical emergency-report of two cases.
    Mele G; Coppi MR; Melpignano A; Quarta G
    Clin Exp Med; 2016 Feb; 16(1):99-101. PubMed ID: 25600700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.